Introducing products bringing GUT wellness


You are here:

Uniquely positioned with niche products

Gastrointestinal Tract infections are one of the major health concerns in many parts of world, including India. A new trend is emerging in Asia as diseases that were once considered “Western” and increasingly found in wealthy countries such as Japan and South Korea are now common in India. Gastrointestinal (GI) diseases in particular are becoming more common and have been linked to changing environmental factors brought on by industrialization, changes in diet, improved sanitation, and the increased use of antibiotics. Common GI diseases include colorectal cancer, gastroesophageal reflux disease, ulcerative colitis (UC), inflammatory bowel disease (IBD), and Crohn’s disease (CD). Due to these factors, medical device companies in the GI space should look to expand their business operations in Asia.

In India, diseases like diarrhoeas, hepatitis, typhoid, TB of the intestinal tract etc. are still prevalent, but what is alarming is the rise of lifestyle diseases like irritable bowel syndrome, Gastroesophageal reflux disease (GERD), inflammatory bowel disease like Crohn’s and non-alcoholic fatty liver and cancers of the food pipe, colon and liver, pancreas and gall bladder.

Working habit and physical activity plays very important role in human health. Sedentary lifestyle tends to suffer from obesity because of less physical activities subsequently leading to a wide range of disease, including gastrointestinal diseases, gastro-esophageal reflux disease, Barrett’s esophagus, erosive esophagitis. Along with quality of water, food habits, increased alcohol consumption and type usually play a very important role in the health of an individual.

Owing to diverse food habits, Indian population suffers from varied gastric disorders. With our novel product portfolio, we have introduced unique products addressing the unmet needs. This market is valued at 14250 cr and growing at +7%.

Our Flagship brands